#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Peter PAGES Email
Head FP&A . DBV Technologies
New York, NY
Locationp**********@dbv-technologies.com
Primary EmailHow to contact Peter PAGES
Join and see Peter's contact info for free!Current Roles
Employees:
223Revenue:
$1.6MAbout
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments to help those with food allergies. With a new class of self-administered and non-invasive product candidates, the company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV's food allergies programs include ongoing clinical trials of product candidates in Phase III, Phase II, and preclinical development. DBV is also pursuing a human proof-of-concept clinical study using their technology for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. Allergy, Food and pediatric allergy, Specific immunotherapyDBV Technologies Address
12 East 49th StreetNew York, NY
United States